Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1609-1615

  Haldar, Subrata ^a,c   Basu, Aruna ^a   Croce, Carlo M ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; DOLASTATIN 10; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOCODAZOLE; OKADAIC ACID; PACLITAXEL; PROTEIN BCL 2; SERINE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

ALANINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; MUTAGENESIS, SITE-DIRECTED; NOCODAZOLE; OKADAIC ACID; OLIGOPEPTIDES; PACLITAXEL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SERINE; TUMOR CELLS, CULTURED;

EID: 0032522885     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. White, E. Life, death and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
3. Tsujimoto, Y., Finger, L., Yunis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science (Washington, DC), 226: 1097-1099, 1984.
4. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. Involvement of the Bcl2 gene in human follicular lymphoma. Science (Washington, DC), 228: 1440-1443, 1985.
5. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
6. Hengartner, M. O., and Horvitz, H. R. C. elegans cell survival gene Ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell, 76: 655-676, 1994.
7. Boise, L. H., Gonzalez-Garcia, M., Postema, C. F., Ding, L., Lindstein, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. Bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 76: 597-608, 1993.
8. Oltvai, Z., Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell, 74: 609-619, 1993.
9. Chittenden, T., Harrington, E. A., O'Conner, R., Flemmington, C., Lutz, R. J., Evan, G. I., and Gould, B. C. Induction of apoptosis by the bcl-2 related gene that functions as a dominant regulator of apoptotic death. Nature (Lond.), 374: 733-736, 1995.
10. Sato, T., Hanada, M., Bodnig, S., Irie, S., Iwana, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H-G., and Reed, J. C. Interactions among members of the bcl-2 protein family analyzed with a yeast two hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994.
11. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
12. L, an inhibitor of programmed cell death. Nature (Lond.), 381: 335-341, 1996.
13. Minn, A. J., Velez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M., and Thompson, C. B. Bcl-X(L) forms an Ion Channel in synthetic lipid membranes. Nature (Lond.), 385: 353-357, 1997.
14. Haldar, S., Jena, N., and Croce, C. M. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
15. Haldar, S., Chintapallli, J., and Croce, C. M. Taxol induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
16. Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
17. Blagosklonny, M. V., Giannakakou, P., Ei-Deiry, W. S., Kingston, D. G. I., Higgs, P. I., Neckers, L., and Fozo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57: 130-135, 1997.
18. Haldar, S., Basu, A., and Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57: 229-233, 1997.
19. L and Bcl-2. EMBO J., 16: 968-977, 1997.
20. Ho, S. N., Hunt, A. D., Horton, R. M., Pullen, J. K., and Pease, L. R. Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, 77: 51-59, 1989.
21. Graham, F. L., and van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-457, 1973.
22. Potter, H., Weir, L., and Leder, P. Enhancer-dependent expression of human k-immunoglobulin gene introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA, 81: 7161-7165, 1984.
23. Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boetner, F. E., Kizu, H., Schmidt, J. M., Baczyynskkyj, L., Tomer, K. B., and Bontems, R. J. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10. J. Am. Chem. Soc., 109: 6883-6885, 1987.
24. Zheng, B., Chambers, T. C., Raynor, R. L., Markham, P. N., Gebel, H. M., Vogler, W. R., and Cuo, J. F. Human leukemic K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-ε, exhibits multidrug resistance phenotype, and express drug pump P-glycoprotein. J. Biol. Chem., 269: 12332-12334, 1994.
25. 2-M stage of the cell cycle results in loss of anti-apoptotic function. Special Conference: Molecular Mechanism of Apoptosis Regulation. Proc. Am. Assoc. Cancer Res., B-87. 1998.
26. Rowinsky, E. K., Onetto, N., Canetta, R. M., and Arbuck, S. G. Taxol, the first of the taxanes, an important new class of antitumor agents. Semin. Oncol., 19: 648-662, 1992.
27. Horwitz, S. B. Mechanism of action of Taxol. Trends Pharmacol. Sci., 13: 134-136, 1992.
28. Bai, R., Pettit, G. R., and Hamel, E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents. J. Biol. Chem., 28: 17141-17149, 1990.
29. Hu, Z. B., Gignac, S. M., Quentmeier, H., Pettit, G. R., and Drexler, H. G. Effects of dolastatin on human B-lymphocytic cell lines. Leuk. Res., 17: 333-339, 1993.
30. Beckwith, M., Urba, W. J., and Longo, D. L. Growth inhibition of human lymphoma cell lines by the marine products, dolastatin 10 and 15. J. Natl. Cancer Inst. (Bethesda), 85: 483-488, 1993.
31. Winterhalter, B. R., Berger, D. P., Pettit, G. R., and Fiebig, H. H. Cytotoxicity of dolastatin 10, dolastatin 15, and dolastatin K333 in human tumor xenografts in vitro. Proc. Am. Assoc. Cancer Res., 32: 402, 1996.
32. Waud, W. R., Dykes, D. J., Pettit, G. R., and Plowman, J. Preclinical antitumor activity of dolastatin 10. Proc. Am. Assoc. Cancer Res., 34: 383, 1993.
33. Ito, T., Deng, X., Carr, B., and May, W. S. Bcl2 phosphorylation required for anti-apoptosis function. J. Biol. Chem., 272: 11671-11673, 1997.
34. Uhlmann, E. J., D'Sa-Eipper, C., Subramanian, T., Wagner, A. J., Hay, N., and Chinnadurai, G. Deletion of a nonconserved region of Bcl2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res., 56: 2506-2509, 1996.
35. Willingham, M. C., and Bhalla, K. Transient mitotic phases localization of Bcl2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J. Histochem. Cytochem., 42: 441-450, 1994.
36. Cohen, J. J., and Duke, R. C. Glucocorticoid activation of calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 132: 38-42, 1984.
37. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
38. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11: 121-139, 1992.